Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Orgenesis Revenue 2013-2024 | ORGS

Orgenesis revenue from 2013 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  
Orgenesis Annual Revenue
(Millions of US $)
2023 $1
2022 $36
2021 $36
2020 $8
2019 $4
2018 $21
2018 $19
2017 $10
2016 $6
2015 $3
2014 $
2013 $
2012 $
2012 $
2011 $
Orgenesis Quarterly Revenue
(Millions of US $)
2024-09-30 $0
2024-06-30 $0
2024-03-31 $0
2023-12-31 $0
2023-09-30 $0
2023-06-30 $0
2023-03-31 $0
2022-12-31 $14
2022-09-30 $8
2022-06-30 $7
2022-03-31 $7
2021-12-31 $7
2021-09-30 $9
2021-06-30 $11
2021-03-31 $9
2020-12-31 $2
2020-09-30 $2
2020-06-30 $2
2020-03-31 $2
2019-12-31 $1
2019-09-30 $1
2019-06-30 $1
2019-03-31 $0
2018-12-31 $8
2018-11-30
2018-08-31 $6
2018-05-31 $4
2018-02-28 $3
2017-11-30
2017-08-31 $3
2017-05-31 $2
2017-02-28 $2
2016-11-30
2016-08-31 $2
2016-05-31 $1
2016-02-29 $2
2015-11-30
2015-08-31 $1
2015-05-31 $1
2015-02-28
2014-11-30
2014-08-31
2014-05-31
2014-02-28
2013-11-30
2013-08-31
2013-05-31
2013-02-28
2012-12-31
2012-11-30
2012-09-30
2012-08-31
2012-06-30
2012-05-31
2012-03-31
2012-02-29
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.005B $0.001B
Orgenesis, Inc. is a biopharmaceutical company. It focused on developing its trans-differentiation technologies for diabetes. The company deals with the combination of cell-based therapy and regenerative medicine into clinical development. Its operating segment consists of Contract Development and Manufacturing Organization and Cellular Therapy Business. Contract Development and Manufacturing Organization segment activity includes MaSTherCell, which specializes in cell therapy development for advanced medicinal products. Cellular Therapy Business segment activity is based on its technology which demonstrates the capacity to induce a shift in the developmental fate of cells from the liver and differentiating them into pancreatic beta cell like insulin producing cells for patients with Type 1 Diabetes. Orgenesis, Inc. is headquartered in Germantown, MD.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $152.450B 14.76
Vertex Pharmaceuticals (VRTX) United States $119.931B 0.00
Bristol Myers Squibb (BMY) United States $114.024B 48.05
Gilead Sciences (GILD) United States $110.170B 19.95
CSL (CSLLY) Australia $85.472B 0.00
Regeneron Pharmaceuticals (REGN) United States $83.165B 18.93
GSK (GSK) United Kingdom $69.120B 8.00
Argenex SE (ARGX) Netherlands $33.739B 0.00
Alnylam Pharmaceuticals (ALNY) United States $30.383B 0.00
BioNTech SE (BNTX) Germany $23.907B 0.00
Biogen (BIIB) United States $23.314B 10.01
Illumina (ILMN) United States $21.419B 78.06
BeiGene (BGNE) Cayman Islands $18.430B 0.00
Incyte (INCY) United States $14.616B 0.00
Moderna (MRNA) United States $14.181B 0.00
Genmab (GMAB) Denmark $13.626B 19.99
BioMarin Pharmaceutical (BMRN) United States $12.087B 28.06
Insmed (INSM) United States $11.859B 0.00
Vaxcyte (PCVX) United States $10.822B 0.00
Bio-Techne Corp (TECH) United States $10.736B 41.45
Sarepta Therapeutics (SRPT) United States $9.986B 90.12
Exelixis (EXEL) United States $9.838B 22.37
QIAGEN (QGEN) Netherlands $9.418B 19.38
Bio-Rad Laboratories (BIO.B) United States $9.375B 31.86
Revolution Medicines (RVMD) United States $9.274B 0.00
Exact Sciences (EXAS) United States $9.130B 0.00
Intra-Cellular Therapies (ITCI) United States $8.844B 0.00
Roivant Sciences (ROIV) United Kingdom $8.283B 0.00
Ascendis Pharma (ASND) Denmark $7.672B 0.00
Repligen (RGEN) United States $6.986B 91.04
Legend Biotech (LEGN) United States $6.962B 0.00
Cytokinetics (CYTK) United States $5.927B 0.00
Halozyme Therapeutics (HALO) United States $5.808B 13.12
Blueprint Medicines (BPMC) United States $5.634B 0.00
Nuvalent (NUVL) United States $5.630B 0.00
Viking Therapeutics (VKTX) United States $5.525B 0.00
Avidity Biosciences (RNA) United States $5.032B 0.00
Krystal Biotech (KRYS) United States $4.911B 81.31
Arcellx (ACLX) United States $4.749B 0.00
Alkermes (ALKS) Ireland $4.561B 15.32
Axsome Therapeutics (AXSM) United States $4.515B 0.00
ADMA Biologics Inc (ADMA) United States $4.501B 47.60
Biohaven (BHVN) United States $4.489B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.132B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.033B 0.00
Immunovant (IMVT) United States $3.909B 0.00
Denali Therapeutics (DNLI) United States $3.605B 0.00
Guardant Health (GH) United States $3.597B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.456B 0.00
Apellis Pharmaceuticals (APLS) United States $3.268B 0.00
Merus (MRUS) Netherlands $3.189B 0.00
ImmunityBio (IBRX) United States $3.129B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.120B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.037B 0.00
Edgewise Therapeutics (EWTX) United States $2.977B 0.00
Vera Therapeutics (VERA) United States $2.929B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.918B 0.00
Amicus Therapeutics (FOLD) United States $2.892B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $2.851B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.790B 21.50
Kymera Therapeutics (KYMR) United States $2.718B 0.00
SpringWorks Therapeutics (SWTX) United States $2.711B 0.00
Zai Lab (ZLAB) China $2.695B 0.00
Vericel (VCEL) United States $2.590B 874.67
Janux Therapeutics (JANX) United States $2.559B 0.00
Belite Bio (BLTE) United States $2.535B 0.00
Iovance Biotherapeutics (IOVA) United States $2.493B 0.00
Scholar Rock Holding (SRRK) United States $2.480B 0.00
Protagonist Therapeutics (PTGX) United States $2.450B 15.45
Longboard Pharmaceuticals (LBPH) United States $2.331B 0.00
IDEAYA Biosciences (IDYA) United States $2.303B 0.00
Keros Therapeutics (KROS) United States $2.294B 0.00
CG Oncology (CGON) United States $2.225B 0.00
Geron (GERN) United States $2.212B 0.00
Twist Bioscience (TWST) United States $2.161B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.136B 0.00
Apogee Therapeutics (APGE) United States $2.128B 0.00
Ligand Pharmaceuticals (LGND) United States $2.111B 52.69
WAVE Life Sciences (WVE) Singapore $2.085B 0.00
Beam Therapeutics (BEAM) United States $1.991B 0.00
Akero Therapeutics (AKRO) United States $1.961B 0.00
Structure Therapeutics (GPCR) United States $1.957B 0.00
NeoGenomics (NEO) United States $1.931B 0.00
Bavarian Nordic (BVNRY) Denmark $1.923B 11.78
Harmony Biosciences Holdings (HRMY) United States $1.894B 15.74
MannKind (MNKD) United States $1.875B 48.57
Disc Medicine (IRON) United States $1.767B 0.00
Galapagos (GLPG) Belgium $1.766B 0.00
Neumora Therapeutics (NMRA) United States $1.751B 0.00
NovoCure (NVCR) Jersey $1.743B 0.00
Fortrea Holdings (FTRE) United States $1.735B 55.26
Tarsus Pharmaceuticals (TARS) United States $1.714B 0.00
Nurix Therapeutics (NRIX) United States $1.624B 0.00
Dynavax Technologies (DVAX) United States $1.605B 93.92
Certara (CERT) United States $1.603B 45.27
Viridian Therapeutics (VRDN) United States $1.595B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.581B 0.00
Celldex Therapeutics (CLDX) United States $1.562B 0.00
Arvinas (ARVN) United States $1.545B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.537B 0.00
Spyre Therapeutics (SYRE) United States $1.502B 0.00
Arcus Biosciences (RCUS) United States $1.437B 0.00
Intellia Therapeutics (NTLA) United States $1.423B 0.00
Myriad Genetics (MYGN) United States $1.388B 0.00
Travere Therapeutics (TVTX) United States $1.383B 0.00
Upstream Bio (UPB) United States $1.365B 0.00
MiMedx (MDXG) United States $1.364B 35.69
Syndax Pharmaceuticals (SNDX) United States $1.351B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.342B 0.00
Praxis Precision Medicines (PRAX) United States $1.337B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.274B 0.00
Kura Oncology (KURA) United States $1.238B 0.00
Gyre Therapeutics (GYRE) United States $1.227B 0.00
ANI Pharmaceuticals (ANIP) United States $1.190B 16.21
Novavax (NVAX) United States $1.173B 0.00
Mesoblast (MESO) Australia $1.146B 0.00
Vir Biotechnology (VIR) United States $1.103B 0.00
Bicara Therapeutics (BCAX) United States $1.098B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.084B 0.00
Zymeworks (ZYME) United States $1.060B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.036B 0.00
Applied Therapeutics (APLT) United States $1.011B 0.00
Cogent Biosciences (COGT) United States $0.983B 0.00
Immatics (IMTX) Germany $0.975B 0.00
Septerna (SEPN) $0.946B 0.00
ArriVent BioPharma (AVBP) United States $0.917B 0.00
LENZ Therapeutics (LENZ) United States $0.913B 0.00
Nuvation Bio (NUVB) United States $0.885B 0.00
89BIO (ETNB) United States $0.842B 0.00
Liquidia Technologies (LQDA) United States $0.833B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.820B 0.00
Cullinan Therapeutics (CGEM) United States $0.807B 0.00
Castle Biosciences (CSTL) United States $0.787B 140.50
AbCellera Biologics (ABCL) Canada $0.783B 0.00
Tyra Biosciences (TYRA) United States $0.779B 0.00
Avid Bioservices (CDMO) United States $0.774B 0.00
Pacira BioSciences (PCRX) United States $0.766B 7.22
Cytek Biosciences (CTKB) United States $0.766B 0.00
Rapport Therapeutics (RAPP) United States $0.766B 0.00
Pliant Therapeutics (PLRX) United States $0.756B 0.00
Erasca (ERAS) United States $0.755B 0.00
Prothena (PRTA) Ireland $0.754B 0.00
Adaptive Biotechnologies (ADPT) United States $0.750B 0.00
Replimune (REPL) United States $0.739B 0.00
CARGO Therapeutics (CRGX) United States $0.736B 0.00
Zenas BioPharma (ZBIO) United States $0.715B 0.00
Dianthus Therapeutics (DNTH) United States $0.691B 0.00
Arbutus Biopharma (ABUS) United States $0.690B 0.00
Entrada Therapeutics (TRDA) United States $0.668B 11.23
BioAge Labs (BIOA) United States $0.656B 0.00
Annexon (ANNX) United States $0.652B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Stoke Therapeutics (STOK) United States $0.637B 0.00
Anavex Life Sciences (AVXL) United States $0.631B 0.00
CorMedix Inc (CRMD) United States $0.627B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.626B 0.00
Immunome (IMNM) United States $0.618B 0.00
Humacyte (HUMA) United States $0.609B 0.00
Abivax SA (ABVX) France $0.601B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.600B 0.00
Oric Pharmaceuticals (ORIC) United States $0.600B 0.00
Tectonic Therapeutic (TECX) United States $0.597B 0.00
MBX Biosciences (MBX) United States $0.588B 0.00
AnaptysBio (ANAB) United States $0.578B 0.00
Oculis Holding AG (OCS) Switzerland $0.573B 0.00
Mineralys Therapeutics (MLYS) United States $0.571B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.569B 0.00
CureVac (CVAC) Germany $0.569B 4.62
IGM Biosciences (IGMS) United States $0.563B 0.00
Pharming Group (PHAR) Netherlands $0.555B 0.00
Third Harmonic Bio (THRD) United States $0.547B 0.00
PureTech Health (PRTC) United States $0.546B 0.00
Sana Biotechnology (SANA) United States $0.540B 0.00
Astria Therapeutics (ATXS) United States $0.529B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.526B 0.00
Olema Pharmaceuticals (OLMA) United States $0.525B 0.00
Terns Pharmaceuticals (TERN) United States $0.524B 0.00
ChromaDex (CDXC) United States $0.521B 682.00
Oxford BioMedica (OXBDF) United Kingdom $0.521B 0.00
MeiraGTx Holdings (MGTX) United States $0.506B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.499B 0.00
GRAIL (GRAL) United States $0.497B 0.00
REGENXBIO (RGNX) United States $0.477B 0.00
Allogene Therapeutics (ALLO) United States $0.476B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.476B 0.00
Aura Biosciences (AURA) United States $0.473B 0.00
GH Research (GHRS) Ireland $0.473B 0.00
ACELYRIN, INC (SLRN) United States $0.471B 0.00
Celcuity (CELC) United States $0.470B 0.00
Neurogene (NGNE) United States $0.448B 0.00
Foghorn Therapeutics (FHTX) United States $0.445B 0.00
Contineum Therapeutics (CTNM) United States $0.444B 0.00
Cartesian Therapeutics (RNAC) United States $0.440B 0.00
Prime Medicine (PRME) United States $0.439B 0.00
Revance Therapeutics (RVNC) United States $0.437B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.434B 0.00
Sangamo Therapeutics (SGMO) United States $0.428B 0.00
Emergent Biosolutions (EBS) United States $0.418B 0.00
Alumis (ALMS) United States $0.418B 0.00
Tango Therapeutics (TNGX) United States $0.414B 0.00
Q32 Bio (QTTB) United States $0.401B 0.00
Alector (ALEC) United States $0.398B 0.00
Northwest Biotherapeutics (NWBO) United States $0.367B 0.00
MaxCyte (MXCT) United States $0.361B 0.00
XOMA Royalty (XOMA) United States $0.356B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.354B 0.00
EnGene Holdings (ENGN) Canada $0.337B 0.00
Kamada (KMDA) Israel $0.334B 20.75
Design Therapeutics (DSGN) United States $0.328B 0.00
Absci (ABSI) United States $0.326B 0.00
Codexis (CDXS) United States $0.316B 0.00
AC Immune (ACIU) Switzerland $0.316B 0.00
Alpha Teknova (TKNO) United States $0.315B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.312B 0.00
Voyager Therapeutics (VYGR) United States $0.308B 7.94
Rezolute (RZLT) United States $0.307B 0.00
Jasper Therapeutics (JSPR) United States $0.306B 0.00
C4 Therapeutics (CCCC) United States $0.304B 0.00
UniQure (QURE) Netherlands $0.302B 0.00
ITeos Therapeutics (ITOS) United States $0.301B 0.00
Prima BioMed (IMMP) Australia $0.298B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.292B 0.00
Kodiak Sciences (KOD) United States $0.291B 0.00
Nautilus Biotechnology (NAUT) United States $0.289B 0.00
Ocugen (OCGN) United States $0.273B 0.00
Mersana Therapeutics (MRSN) United States $0.273B 0.00
Atea Pharmaceuticals (AVIR) United States $0.272B 0.00
Poseida Therapeutics (PSTX) United States $0.269B 0.00
Urogen Pharma (URGN) United States $0.262B 0.00
Eton Pharmaceuticals (ETON) United States $0.259B 0.00
Abeona Therapeutics (ABEO) United States $0.255B 0.00
Anika Therapeutics (ANIK) United States $0.253B 0.00
Semper Paratus Acquisition (TVGN) United States $0.249B 0.00
Benitec Biopharma (BNTC) United States $0.248B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.247B 0.00
Artiva Biotherapeutics (ARTV) United States $0.244B 0.00
ATyr Pharma (ATYR) United States $0.244B 0.00
Precigen (PGEN) United States $0.240B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.240B 0.00
Sutro Biopharma (STRO) United States $0.238B 0.00
Biomea Fusion (BMEA) United States $0.237B 0.00
Lifecore Biomedical (LFCR) United States $0.236B 0.00
TScan Therapeutics (TCRX) United States $0.234B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.231B 0.00
BioStem Technologies (BSEM) $0.231B 20.44
Fate Therapeutics (FATE) United States $0.230B 0.00
GENFIT S.A (GNFT) France $0.225B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.222B 0.00
Editas Medicine (EDIT) United States $0.220B 0.00
Molecular Partners AG (MOLN) Switzerland $0.215B 0.00
Trevi Therapeutics (TRVI) United States $0.211B 0.00
Zura Bio (ZURA) United States $0.206B 0.00
Amarin (AMRN) Ireland $0.205B 0.00
XBiotech (XBIT) United States $0.203B 0.00
Climb Bio (CLYM) United States $0.202B 0.00
Inozyme Pharma (INZY) United States $0.201B 0.00
Inhibrx Biosciences (INBX) United States $0.200B 0.00
Solid Biosciences (SLDB) United States $0.194B 0.00
Compass Therapeutics (CMPX) United States $0.190B 0.00
Opthea (OPT) Australia $0.189B 0.00
Kyverna Therapeutics (KYTX) United States $0.188B 0.00
2seventy Bio (TSVT) United States $0.182B 0.00
Caribou Biosciences (CRBU) United States $0.180B 0.00
Nkarta (NKTX) United States $0.179B 0.00
Verastem (VSTM) United States $0.178B 0.00
Bright Minds Biosciences (DRUG) United States $0.176B 0.00
ScPharmaceuticals (SCPH) United States $0.173B 0.00
Instil Bio (TIL) United States $0.173B 0.00
DiaMedica Therapeutics (DMAC) United States $0.171B 0.00
Actuate Therapeutics (ACTU) United States $0.170B 0.00
Gossamer Bio (GOSS) United States $0.168B 0.00
Greenwich LifeSciences (GLSI) United States $0.165B 0.00
Fulcrum Therapeutics (FULC) United States $0.162B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.159B 0.00
CAMP4 Therapeutics (CAMP) United States $0.158B 0.00
Tenaya Therapeutics (TNYA) United States $0.156B 0.00
Checkpoint Therapeutics (CKPT) United States $0.154B 0.00
Skye Bioscience (SKYE) United States $0.150B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.150B 0.00
Black Diamond Therapeutics (BDTX) United States $0.148B 0.00
Cabaletta Bio (CABA) United States $0.148B 0.00
Sagimet Biosciences (SGMT) United States $0.145B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.144B 0.00
Inventiva S.A (IVA) France $0.143B 0.00
Adverum Biotechnologies (ADVM) United States $0.143B 0.00
Seer (SEER) United States $0.136B 0.00
PepGen (PEPG) United States $0.134B 0.00
Ventyx Biosciences (VTYX) United States $0.132B 0.00
Repare Therapeutics (RPTX) Canada $0.132B 0.00
Cardiff Oncology (CRDF) United States $0.132B 0.00
Vigil Neuroscience (VIGL) United States $0.130B 0.00
Oncobiologics (OTLK) United States $0.128B 0.00
Compugen (CGEN) Israel $0.126B 70.50
Candel Therapeutics (CADL) United States $0.123B 0.00
Alto Neuroscience (ANRO) United States $0.122B 0.00
Elutia (ELUT) United States $0.121B 0.00
Rani Therapeutics Holdings (RANI) United States $0.121B 0.00
Akoya Biosciences (AKYA) United States $0.119B 0.00
Puma Biotechnology (PBYI) United States $0.119B 5.04
Scilex Holding (SCLX) United States $0.117B 0.00
Innate Pharma S.A (IPHA) France $0.117B 0.00
Adlai Nortye (ANL) Cayman Islands $0.115B 0.00
TELA Bio (TELA) United States $0.115B 0.00
InflaRx (IFRX) Germany $0.115B 0.00
Inovio Pharmaceuticals (INO) United States $0.111B 0.00
INmune Bio (INMB) United States $0.110B 0.00
Adherex Technologies (FENC) United States $0.109B 0.00
Coya Therapeutics (COYA) United States $0.106B 0.00
Cellectis S.A (CLLS) France $0.104B 0.00
Allakos (ALLK) United States $0.104B 0.00
Generation Bio (GBIO) United States $0.103B 0.00
Cidara Therapeutics (CDTX) United States $0.101B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.099B 0.00
BioHarvest Sciences (BHST) Canada $0.099B 0.00
Nuvectis Pharma (NVCT) United States $0.096B 0.00
Adagene (ADAG) China $0.096B 0.00
Immunic (IMUX) United States $0.095B 0.00
Monopar Therapeutics (MNPR) United States $0.095B 0.00
Annovis Bio (ANVS) United States $0.094B 0.00
Seres Therapeutics (MCRB) United States $0.094B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.094B 0.00
Galena Biopharma (SLS) United States $0.093B 0.00
Genenta Science S.p.A (GNTA) Italy $0.092B 0.00
HilleVax (HLVX) United States $0.091B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.091B 0.00
Invivyd (IVVD) United States $0.090B 0.00
MediciNova (MNOV) United States $0.090B 0.00
FibroBiologics (FBLG) United States $0.089B 0.00
Coherus BioSciences (CHRS) United States $0.086B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.085B 0.00
I-Mab (IMAB) China $0.085B 0.00
Ikena Oncology (IKNA) United States $0.082B 0.00
Genelux (GNLX) United States $0.082B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.080B 0.00
Renovaro (RENB) United States $0.079B 0.00
Werewolf Therapeutics (HOWL) United States $0.079B 0.00
Quince Therapeutics (QNCX) United States $0.078B 0.00
Adicet Bio (ACET) United States $0.078B 0.00
Chimerix (CMRX) United States $0.077B 0.00
ZIVO Bioscience (ZIVO) United States $0.076B 0.00
Oncolytics Biotech (ONCY) Canada $0.076B 0.00
BioAtla (BCAB) United States $0.075B 0.00
Ovid Therapeutics (OVID) United States $0.075B 0.00
PDS Biotechnology (PDSB) United States $0.075B 0.00
Clearside Biomedical (CLSD) United States $0.075B 0.00
23andMe Holding (ME) United States $0.074B 0.00
VistaGen Therapeutics (VTGN) United States $0.073B 0.00
Aerovate Therapeutics (AVTE) United States $0.073B 0.00
CytomX Therapeutics (CTMX) United States $0.071B 5.35
Leap Therapeutics (LPTX) United States $0.070B 0.00
Atara Biotherapeutics (ATRA) United States $0.069B 0.00
X4 Pharmaceuticals (XFOR) United States $0.069B 0.00
Aligos Therapeutics (ALGS) United States $0.069B 0.00
ALX Oncology Holdings (ALXO) United States $0.068B 0.00
Boundless Bio (BOLD) United States $0.067B 0.00
CervoMed (CRVO) United States $0.066B 0.00
Spero Therapeutics (SPRO) United States $0.064B 16.86
Agenus (AGEN) United States $0.064B 0.00
BeyondSpring (BYSI) United States $0.063B 0.00
Bluebird Bio (BLUE) United States $0.062B 0.00
Aileron Therapeutics (ALRN) United States $0.062B 0.00
Entera Bio (ENTX) Israel $0.062B 0.00
Connect Biopharma Holdings (CNTB) United States $0.061B 0.00
Cue Biopharma (CUE) United States $0.061B 0.00
Vor Biopharma (VOR) $0.059B 0.00
Elicio Therapeutics (ELTX) United States $0.059B 0.00
Shattuck Labs (STTK) United States $0.059B 0.00
Precision BioSciences (DTIL) United States $0.058B 0.00
DBV Technologies S.A (DBVT) France $0.057B 0.00
Affimed (AFMD) Germany $0.056B 0.00
Immuneering (IMRX) United States $0.056B 0.00
OnKure Therapeutics (OKUR) United States $0.055B 0.00
Kezar Life Sciences (KZR) United States $0.054B 0.00
Enzo Biochem (ENZ) United States $0.054B 0.00
Theratechnologies (THTX) Canada $0.054B 0.00
Celularity (CELU) United States $0.054B 0.00
IO Biotech (IOBT) Denmark $0.054B 0.00
VTv Therapeutics (VTVT) United States $0.052B 0.00
Aadi Bioscience (AADI) United States $0.052B 0.00
Kronos Bio (KRON) United States $0.051B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.048B 0.00
BGM Group (BGM) China $0.048B 0.00
Omega Therapeutics (OMGA) United States $0.046B 0.00
Xilio Therapeutics (XLO) United States $0.046B 0.00
CalciMedica (CALC) United States $0.045B 0.00
Immix Biopharma (IMMX) United States $0.044B 0.00
Intensity Therapeutics (INTS) United States $0.044B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.043B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.041B 0.00
Rallybio (RLYB) United States $0.041B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.041B 0.00
Fortress Biotech (FBIO) United States $0.039B 0.00
Rapt Therapeutics (RAPT) United States $0.039B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.038B 0.00
Lantern Pharma (LTRN) United States $0.038B 0.00
Clene (CLNN) United States $0.038B 0.00
Lumos Pharma (LUMO) United States $0.037B 0.00
NextCure (NXTC) United States $0.037B 0.00
Beyond Air (XAIR) United States $0.036B 0.00
HOOKIPA Pharma (HOOK) United States $0.036B 0.00
OKYO Pharma (OKYO) $0.036B 0.00
Opus Genetics (IRD) United States $0.033B 0.00
Dyadic (DYAI) United States $0.033B 0.00
Alpha Cognition (ACOG) Canada $0.032B 0.00
Estrella Immunopharma (ESLA) United States $0.032B 0.00
Passage Bio (PASG) United States $0.032B 0.00
Promis Neurosciences (PMN) Canada $0.032B 0.00
Lexaria Bioscience (LEXX) Canada $0.032B 0.00
Grace Therapeutics (GRCE) Canada $0.032B 0.00
Elevation Oncology (ELEV) United States $0.031B 0.00
KALA BIO (KALA) United States $0.031B 0.00
Pluri (PLUR) Israel $0.030B 0.00
AN2 Therapeutics (ANTX) United States $0.030B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.029B 0.00
SAB Biotherapeutics (SABS) United States $0.029B 0.00
Longeveron (LGVN) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
RenovoRx (RNXT) United States $0.026B 0.00
Cadrenal Therapeutics (CVKD) United States $0.026B 0.00
Athira Pharma (ATHA) United States $0.026B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.026B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.025B 0.00
Equillium (EQ) United States $0.025B 0.00
Bionano Genomics (BNGO) United States $0.025B 0.00
Ocean Biomedical (OCEA) United States $0.025B 0.00
BioXcel Therapeutics (BTAI) United States $0.024B 0.00
LakeShore Biopharma (LSB) China $0.024B 0.00
Chemomab Therapeutics (CMMB) Israel $0.024B 0.00
Pulmatrix (PULM) United States $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.024B 0.00
Curis (CRIS) United States $0.024B 0.00
GeoVax Labs (GOVX) United States $0.023B 0.00
Cocrystal Pharma (COCP) United States $0.022B 0.00
Femasys (FEMY) United States $0.022B 0.00
Bolt Biotherapeutics (BOLT) United States $0.022B 0.00
BRIACELL THERAP (BCTX) Canada $0.021B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.021B 0.00
BioAffinity Technologies (BIAF) United States $0.020B 0.00
UNITY Biotechnology (UBX) United States $0.020B 0.00
Spruce Biosciences (SPRB) United States $0.020B 0.00
Cyclo Therapeutics (CYTH) United States $0.020B 0.00
Cognition Therapeutics (CGTX) United States $0.019B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.019B 0.00
Aprea Therapeutics (APRE) United States $0.018B 0.00
Cara Therapeutics (CARA) United States $0.017B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.017B 0.00
Tenax Therapeutics (TENX) United States $0.017B 0.00
Synlogic (SYBX) United States $0.016B 0.00
IN8bio (INAB) United States $0.016B 0.00
Gelteq (GELS) $0.016B 0.00
Cingulate (CING) United States $0.013B 0.00
COSCIENS Biopharma (CSCI) Canada $0.012B 0.00
Novogen (KZIA) Australia $0.012B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
HCW Biologics (HCWB) United States $0.011B 0.00
Mustang Bio (MBIO) United States $0.011B 0.00
Onconetix (ONCO) United States $0.011B 0.00
Imunon (IMNN) United States $0.010B 0.00
Apollomics (APLM) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Biorestorative Therapies (BRTX) United States $0.010B 0.00
Quantum Biopharma (QNTM) Canada $0.010B 0.00
Vincerx Pharma (VINC) United States $0.010B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
Biora Therapeutics (BIOR) United States $0.010B 0.00
Aytu BioPharma (AYTU) United States $0.010B 0.00
NKGen Biotech (NKGN) United States $0.009B 0.00
Ensysce Biosciences (ENSC) United States $0.009B 0.00
Evogene (EVGN) Israel $0.009B 0.00
Soligenix (SNGX) United States $0.009B 0.00
Forte Biosciences (FBRX) United States $0.009B 0.00
Evaxion Biotech (EVAX) Denmark $0.008B 0.00
Galecto (GLTO) Denmark $0.008B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
TuHURA Biosciences (HURA) United States $0.007B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
Syros Pharmaceuticals (SYRS) United States $0.007B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.007B 0.00
Edesa Biotech (EDSA) Canada $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Aptose Biosciences (APTO) Canada $0.007B 0.00
Eyenovia (EYEN) United States $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.006B 0.00
Organovo Holdings (ONVO) United States $0.006B 0.00
Exicure (XCUR) United States $0.006B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Vaccinex (VCNX) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Bionomics (BNOX) Australia $0.005B 0.00
Carmell (CTCX) United States $0.005B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Eterna Therapeutics (ERNA) United States $0.005B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Biofrontera (BFRI) United States $0.004B 0.00
Dogwood Therapeutics (DWTX) United States $0.004B 0.00
NuCana (NCNA) United Kingdom $0.004B 0.00
BioCardia (BCDA) United States $0.004B 0.00
Aptevo Therapeutics (APVO) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Polyrizon (PLRZ) $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
NAYA Biosciences (NAYA) United States $0.003B 0.00
Synaptogenix (SNPX) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.003B 0.00
Silexion Therapeutics Corp (SLXN) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.003B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
180 Life Sciences (ATNF) United States $0.003B 0.00
Citius Oncology (CTOR) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
GRI Bio (GRI) United States $0.002B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
TFF Pharmaceuticals (TFFP) United States $0.001B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.001B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.001B 0.00
Elevai Labs (ELAB) United States $0.000B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
Windtree Therapeutics (WINT) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00